Status:
COMPLETED
Early Identification of Warfarin Maintenance Dosage
Lead Sponsor:
University of Padova
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
Initiation of warfarin therapy is problematic. The investigators goal was to evaluate if a new demographic/pharmacogenetic algorithm is better than a usual algorithm based on INR value at day five aft...
Detailed Description
The objective of this randomized study is to evaluate the accuracy of a new demographic/pharmacogenetic as compared to usual warfarin dosing algorithm in predicting warfarin maintenance dose. In patie...
Eligibility Criteria
Inclusion
- Age \>18 years
- Indication to warfarin with INR between 2.0 and 3.0
Exclusion
- Pregnancy
- Drug interactions
- Basal INR \> 1.2
Key Trial Info
Start Date :
October 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2012
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT01178034
Start Date
October 1 2009
End Date
October 1 2012
Last Update
October 23 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Thrombosis Centre
Padua, Italy, 35128